Agfa-Gevaert N.V.

Agfa-Gevaert N.V.

AFGVF
Agfa-Gevaert N.V.US flagOther OTC
0.57
USD
- -
- -
88.40MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
17.08
15.62
15.77
15.12
14.56
13.06
11.77
10.19
11.26
7.33
7.43
7.35
7.01
6.99
Basic EPS, GAAP
0.24
0.3
0.37
0.42
0.22
-0.14
-0.32
3.65
-0.11
-1.41
-0.66
-0.59
-0.46
-0.4
Free Cash Flow per Basic Share
0.4
0.68
0.67
0.58
-0.04
-0.26
0.73
-0.91
-0.74
-0.64
-0.19
-0.03
0.41
0.28
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
5.07
5.34
5.71
6.13
6.35
6.21
5.9
9.53
9.42
7.87
7.31
6.71
6.57
6.51
Tangible Book Value per Share
-1.49
-2.8
-2.11
-2.2
-1.68
-1.94
-3.05
1.7
2.2
1.8
0.88
0.38
-0.08
0.03
Basic Weighted Avg Shares
168
168
168
168
168
168
168
168
156
156
155
155
155
154
Sales/Revenue/Turnover
2,865
2,620
2,646
2,537
2,443
2,191
1,975
1,709
1,760
1,145
1,150
1,138
1,086
1,080
Operating Margin (%)
7.71
6.15
6.76
7.69
6.22
3.33
3.14
1.4
1.14
-3.32
0.43
0.97
0.74
-2.78
Depreciation Expense
86
69
61
72
56
54
94
69
62
63
42
42
36
36
Net Income, GAAP
41
50
62
70
37
-24
-53
613
-17
-221
-102
-92
-71
-62
Effective Tax Rate (%)
46.74
23.38
18.39
30.43
54.08
154.55
- -
- -
1,500
- -
- -
- -
- -
3.12
Profit Margin (%)
1.43
1.91
2.34
2.76
1.51
-1.1
-2.68
35.87
-0.97
-19.3
-8.87
-8.08
-6.54
-5.74
Working Capital
699
550
567
568
563
607
473
952
742
568
404
397
316
336
LT Debt
319
125
137
74
47
219
224
54
46
41
68
141
152
184
Total Equity
368
146
268
252
307
290
130
621
686
561
396
325
256
246
Return on Invested Capital (%)
16.72
18.18
25.49
26.86
14.91
-7.05
- -
- -
-35.78
- -
- -
- -
- -
- -
Return on Capital (%)
5.28
6.51
7.12
7.52
3.98
-4.35
- -
- -
-13.03
- -
- -
- -
- -
-3.33
Return on Common Equity (%)
4.94
5.72
6.69
7.05
3.54
-2.28
-5.22
47.35
-1.11
-16.37
-8.64
-8.48
-6.91
-6.13

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
14
17
12
LT Borrowings
131
111
141
LT Finance Leases
32
41
43
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
155
155
155
Market Capitalization
155
102
76

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
725
719
726
Cash, Cash Equivalents & STI
65
91
84
Accounts Receivable, Net
148
169
143
Inventories
305
254
330
Total Current Liabilities
359
403
390
Payables & Accruals
- -
- -
- -
ST Debt
14
17
12
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
25.65%
-15.26%
-21.23%
Free Cash Flow
-195.89%
-373.93%
-1,675%
Net Income, GAAP
-32.41%
202.15%
-22.83%
Sales/Revenue/Turnover
-7.86%
-7.43%
-4.57%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
250
286
277
325
1,138
2025
242
281
257
306
1,086
2026
236
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.14
0.03
-0.08
-0.4
-0.59
2025
-0.13
- -
-0.12
-0.4
-0.46
2026
-0.08
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Pascal Juery
Full Time Employees
4,765
Sector
Industrials
Industry
Industrial - Machinery
Address
Septestraat 27 Mortsel Belgium 2640
IPO Date
Sep 9, 2009
Website
agfa.com
Business
Agfa-Gevaert N.V. (AFGVF) develops, produces and distributes analog and digital imaging systems and IT solutions primarily for the healthcare sector, printing industry and specific industrial applications; its core offerings span three divisions including HealthCare IT with enterprise imaging platforms, XERO Universal Viewer and cloud-based solutions for radiology workflow management; Radiology Solutions encompassing direct radiography flat panels, computed radiography systems, X-ray artificial intelligence tools and medical films; and Digital Print & Chemicals featuring inks, large-format printers, synthetic paper, offset plates, prepress systems and hydrogen membranes under ZIRFON for green energy applications. Founded in 1964 through the merger of Agfa AG (established 1867) and Gevaert Photo-Producten N.V., the company maintains headquarters in Mortsel, Belgium, with major production and research facilities in Belgium, the United States, Canada, Germany, Austria, China and Brazil; it operates sales organizations in over 40 countries worldwide, targeting hospitals, diagnostic centers, printers and industrial clients. Recent developments include a major deal with Alliance Medical for cloud-based Enterprise Imaging at 120 UK and Ireland sites, a strategic partnership with DHS for print engines in monochrome and polychrome toner lines, resolution of the long-standing AgfaPhoto legal dispute via favorable arbitration, a new revolving credit facility with four financial institutions, launch of advanced inkjet centers and printers, a self-funding cost-reduction program targeting 50 million euro savings by 2027 in traditional film activities with initial benefits in late 2025, and sustained growth in Green Hydrogen Solutions featuring ZIRFON membranes for global projects.

Company News

APIChat
  • Agfa-Gevaert delivers robust Q1 2026 performance amid market challenges

  • Agfa-Gevaert: Convening of Annual General Meeting

  • Agfa-Gevaert Group in 2025: strong Q4 profitability and free cash flow – good step-up in FY profitability in HealthCare IT and Digital Print & Chemicals

  • Agfa-Gevaert (OTCMKTS:AFGVF) Shares Down 50.8% – What’s Next?

  • Agfa-Gevaert NV (AFGVY) Q3 2025 Earnings Call Transcript

  • Agfa-Gevaert NV signs new revolving credit facility - Regulated information - Contains inside information

  • Arbitral Tribunal acting under ICC Rules of Arbitration issues final award in an arbitration between Agfa-Gevaert and the insolvency receiver of AgfaPhoto GmbH

  • Agfa-Gevaert NV (AFGVF) Q1 2025 Earnings Call Transcript

  • The Agfa-Gevaert Group in Q1 2025: adjusted EBITDA stable versus Q1 2024 – improved mix and good cost control compensated for film market decline

  • Annual General Meeting of Agfa-Gevaert NV - regulated information

  • Agfa-Gevaert NV (AFGVF) Q4 2024 Earnings Call Transcript

  • The Agfa-Gevaert Group in 2024: strong performance from growth engines offsets decline in traditional film markets - regulated information

  • Extraordinary General Meeting of Agfa-Gevaert NV - regulated information

  • Special General Meeting of Agfa-Gevaert NV

  • Agfa-Gevaert NV (AFGVF) Q3 2024 Earnings Call Transcript

  • The Agfa-Gevaert Group in Q3 2024: stable sales, adjusted EBITDA at 15 million euro - regulated information

  • Fiona Lam appointed as CFO for the Agfa-Gevaert Group - Regulated information - Contains inside information

  • The Agfa-Gevaert Group in Q2 2024: solid quarter, powered by growth engines - regulated information - inside information

  • Agfa-Gevaert NV (AFGVF) Q1 2024 Earnings Call Transcript

  • The Agfa-Gevaert Group in Q1 2024: weak start of the year, full year outlook maintained - regulated information